go to medicines.ie homepage
Font Size
Search for:  
select
  Advanced Search

Roche Products (Ireland) Ltd
3004 Lake Drive, Citywest, Naas Road, Dublin 24,
Telephone: +353 1 469 0700
Fax: +353 1 469 0791
Medical Information e-mail: ireland.druginfo@roche.com
Patient Information Leaflet last updated on medicines.ie: 23/12/2011
PIL Avastin 25mg/ml concentrate for solution for infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 23/12/2011 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
  • Change to how the medicine works
  • Change to date of revision
Updated on 02/12/2011 and displayed until 23/12/2011
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 05/08/2011 and displayed until 02/12/2011
Reasons for adding or updating:
  • Change to side-effects
Updated on 08/07/2011 and displayed until 05/08/2011
Reasons for adding or updating:
  • Change to, or new use for medicine
Updated on 07/03/2011 and displayed until 08/07/2011
Reasons for adding or updating:
  • Change to, or new use for medicine
Updated on 11/01/2011 and displayed until 07/03/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 08/09/2010 and displayed until 11/01/2011
Reasons for adding or updating:
  • Change to side-effects
Updated on 20/07/2010 and displayed until 08/09/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 10/06/2010 and displayed until 20/07/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 22/01/2010 and displayed until 10/06/2010
Reasons for adding or updating:
  • Change to storage instructions
  • Change to side-effects
  • Change to how the medicine works
  • Change to further information section
Updated on 30/07/2009 and displayed until 22/01/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 08/04/2009 and displayed until 30/07/2009
Reasons for adding or updating:
  • Change of contraindications
Updated on 23/09/2008 and displayed until 08/04/2009
Reasons for adding or updating:
  • Change to side-effects
Updated on 12/02/2008 and displayed until 23/09/2008
Reasons for adding or updating:
  • Change to side-effects
Updated on 29/01/2008 and displayed until 12/02/2008
Reasons for adding or updating:
  • Change to, or new use for medicine
Updated on 12/12/2007 and displayed until 29/01/2008
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 12/11/2007 and displayed until 12/12/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 29/08/2007 and displayed until 12/11/2007
Reasons for adding or updating:
  • Change to, or new use for medicine
  • Change to warnings or special precautions for use
  • Change to dosage and administration
  • Change to drug interactions
  • Change to side-effects
Updated on 03/05/2007 and displayed until 29/08/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 13/04/2007 and displayed until 03/05/2007
Reasons for adding or updating:
  • Change to date of revision
Updated on 19/07/2006 and displayed until 13/04/2007
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 11/01/2006 and displayed until 19/07/2006
Reasons for adding or updating:
  • Change to date of revision
  • Improved electronic presentation
Updated on 10/03/2005 and displayed until 11/01/2006
Reasons for adding or updating:
  • New PIL for new product

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
  Bevacizumab